Jae Hyung Park mainly investigates Drug delivery, Nanoparticle, In vivo, Pharmacology and Chitosan. His work on Drug carrier is typically connected to Human health as part of general Drug delivery study, connecting several disciplines of science. His Nanoparticle research incorporates elements of Surface modification, Hydrophobic effect, Polymer chemistry and Biomedical engineering.
His work deals with themes such as Biophysics, Biochemistry, Photodynamic therapy and Hyaluronic acid, which intersect with In vivo. His Biochemistry study combines topics from a wide range of disciplines, such as Cancer cell and Copolymer. His study focuses on the intersection of Pharmacology and fields such as Doxorubicin with connections in the field of Cytotoxicity, Pharmacokinetics and Toxicity.
His primary areas of investigation include Radiology, Nanoparticle, Drug delivery, In vivo and Hyaluronic acid. His Radiology research is multidisciplinary, relying on both Hepatocellular carcinoma and Artery, Surgery. Jae Hyung Park focuses mostly in the field of Nanoparticle, narrowing it down to matters related to Amphiphile and, in some cases, Micelle and Polymer chemistry.
His research integrates issues of Biophysics, Pharmacology and Doxorubicin in his study of Drug delivery. As a part of the same scientific family, Jae Hyung Park mostly works in the field of Biophysics, focusing on Cancer cell and, on occasion, Cancer research. His Hyaluronic acid study frequently links to other fields, such as Biochemistry.
Jae Hyung Park mostly deals with Cancer research, Nanoparticle, Drug delivery, Cancer cell and Photodynamic therapy. The various areas that Jae Hyung Park examines in his Cancer research study include Cancer, Sonodynamic therapy, Nanomedicine and Cancer immunotherapy. His Nanoparticle study is concerned with the field of Nanotechnology as a whole.
Jae Hyung Park combines subjects such as Chemotherapy, Doxorubicin, Hyaluronic acid, Cancer therapy and Pharmacology with his study of Drug delivery. His studies in Doxorubicin integrate themes in fields like Dextran, Toxicity, Cytotoxicity, Drug carrier and Nanocarriers. His Biophysics study combines topics in areas such as Colloidal gold, Click chemistry and In vivo.
His main research concerns Drug delivery, Cancer research, Doxorubicin, Biophysics and Nanotechnology. Jae Hyung Park studies Drug delivery, namely Drug carrier. Jae Hyung Park works mostly in the field of Drug carrier, limiting it down to concerns involving Polymeric micelles and, occasionally, Hyaluronic acid.
His Doxorubicin research is multidisciplinary, incorporating elements of Systemic administration and Toxicity. His work on Nanoparticle and Quantum dot as part of general Nanotechnology study is frequently connected to Inorganic Chemical, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them. The concepts of his Iron oxide nanoparticles study are interwoven with issues in Biochemistry and In vivo.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Targeted delivery of low molecular drugs using chitosan and its derivatives.
Jae Hyung Park;Gurusamy Saravanakumar;Kwang Meyung Kim;Ick Chan Kwon.
Advanced Drug Delivery Reviews (2010)
Cellular uptake mechanism and intracellular fate of hydrophobically modified glycol chitosan nanoparticles
Hae Yun Nam;Seok Min Kwon;Seok Min Kwon;Hyunjin Chung;Hyunjin Chung;Seung Young Lee.
Journal of Controlled Release (2009)
Polymeric nanomedicine for cancer therapy
Jae Hyung Park;Seulki Lee;Jong Ho Kim;Kyeongsoon Park.
Progress in Polymer Science (2008)
Self-assembled hyaluronic acid nanoparticles for active tumor targeting.
Ki Young Choi;Hyunjin Chung;Hyunjin Chung;Kyung Hyun Min;Kyung Hyun Min;Hong Yeol Yoon.
Hepatic tumors: predisposing factors for complications of transcatheter oily chemoembolization.
Jin Wook Chung;Jae Hyung Park;Joon Koo Han;Byung Ihn Choi.
Porous chitosan scaffold containing microspheres loaded with transforming growth factor-β1: Implications for cartilage tissue engineering
Sung Eun Kim;Jae Hyung Park;Yong Woo Cho;Hesson Chung.
Journal of Controlled Release (2003)
Antitumor efficacy of cisplatin-loaded glycol chitosan nanoparticles in tumor-bearing mice
Jong Ho Kim;Yoo Shin Kim;Kyeongsoon Park;Seulki Lee.
Journal of Controlled Release (2008)
Biodegradable Polymers for Microencapsulation of Drugs
Jae Hyung Park;Mingli Ye;Kinam Park.
Hydrophobically modified glycol chitosan nanoparticles as carriers for paclitaxel.
Jong Ho Kim;Yoo Shin Kim;Sungwon Kim;Sungwon Kim;Jae Hyung Park.
Journal of Controlled Release (2006)
Tumor-homing multifunctional nanoparticles for cancer theragnosis: Simultaneous diagnosis, drug delivery, and therapeutic monitoring
Kwangmeyung Kim;Jong Ho Kim;Hyungkyu Park;Yoo Shin Kim.
Journal of Controlled Release (2010)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: